Ju Fu Tang Biotech Holdings Co (HKSE:08217) EPS without NRI: HK$-0.03 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08217 Ju Fu Tang Biotech Holdings Co Ltd HKSE:08217
36 GF Score
Price HK$0.11
GF Value HK$0.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ju Fu Tang Biotech Holdings Co EPS without NRI?

Ju Fu Tang Biotech Holdings Co HKSE:08217 +12.63% 36 EPS without NRI is HK$-0.03 as of Mar. 2026. GuruFocus rates HKSE:08217 with a GF Score™ of 36/100 and a GF Value™ of HK$0.15 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,345 Construction companies, Ju Fu Tang Biotech Holdings Co ranks worse than 59.93% on this metric.

Ju Fu Tang Biotech Holdings Co's earnings per share without non-recurring items for the six months ended in Mar. 2026 was HK$-0.02. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was HK$-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Ju Fu Tang Biotech Holdings Co's EPS without NRI or its related term are showing as below:

HKSE:08217' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -6.3   Med: 19.1   Max: 58.9
Current: 2.4

HKSE:08217's 3-Year EPS without NRI Growth Rate is ranked worse than
59.93% of 1345 companies
in the Construction industry
Industry Median: 9 vs HKSE:08217: 2.40

Ju Fu Tang Biotech Holdings Co's EPS (Diluted) for the six months ended in Mar. 2026 was HK$0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.08.

Ju Fu Tang Biotech Holdings Co's EPS (Basic) for the six months ended in Mar. 2026 was HK$0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.08.


Ju Fu Tang Biotech Holdings Co  (HKSE:08217) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ju Fu Tang Biotech Holdings Co EPS without NRI Related Terms


Ju Fu Tang Biotech Holdings Co EPS without NRI Historical Data

* Premium members only.

The historical data trend for Ju Fu Tang Biotech Holdings Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ju Fu Tang Biotech Holdings Co EPS without NRI Chart

Ju Fu Tang Biotech Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.03 -0.02 -0.03 -0.03

Ju Fu Tang Biotech Holdings Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.00 -0.02 -0.01 -0.02

HKSE:08217 vs PWR, FIX, EME: EPS without NRI Comparison

For the Engineering & Construction subindustry, Ju Fu Tang Biotech Holdings Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ju Fu Tang Biotech Holdings Co PE Ratio without NRI vs Construction Industry

For the Construction industry and Industrials sector, Ju Fu Tang Biotech Holdings Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Ju Fu Tang Biotech Holdings Co's PE Ratio without NRI falls into.


HKSE:08217
36GF Score
Ju Fu Tang Biotech Holdings Co Ltd HKSE:08217
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ju Fu Tang Biotech Holdings Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of HK$-0.03 mean?
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a EPS without NRI of HK$-0.03 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. According to the industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #806 out of 1345 companies in the Construction industry, placing it in the top 59.9%.
Is Ju Fu Tang Biotech Holdings Co's EPS without NRI too high?
Ju Fu Tang Biotech Holdings Co's current EPS without NRI is HK$-0.03. Based on the distribution chart, Ju Fu Tang Biotech Holdings Co ranks #806 out of 1345 companies in the Construction industry, which is below the industry midpoint. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's EPS without NRI compare to PWR and FIX?
According to the Construction industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #806 out of 1345 companies for EPS without NRI. This places Ju Fu Tang Biotech Holdings Co in the lower half of its industry. The industry median EPS without NRI is 9.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Construction company?
The median EPS without NRI among Construction companies is 9.00, based on 1,345 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. For the Construction industry, the median EPS without NRI is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current EPS without NRI is HK$-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 28.7% below its estimated fair value. The current EPS without NRI is HK$-0.03. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current EPS without NRI is HK$-0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?

Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued. The current stock price of HK$0.11 is trading 28.7% below its estimated GF Value™ of HK$0.15. GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.

Key valuation signals for HKSE:08217:

  • EPS without NRI: HK$-0.03
  • GF Value™: HK$0.15 vs. price of HK$0.11 (28.7% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ju Fu Tang Biotech Holdings Co Business Description

Address 489 Hennessy Road, Unit 2202, 22nd Floor, Causeway Bay Plaza I, Causeway Bay, Hong Kong, HKG
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score

Get the complete analysis for HKSE:08217

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.11
Price
HK$0.15
GF Value